Dr. Jennifer Brown

Postdoctoral Scientific Collaborator


2021 PhD in Medical Biological Research

2019 MAS Development & Cooperation

2016 MSc Biology (Cell Biology)

2014 BSc Biology


Brown J.A, Nsakala B.L, Mokhele K, Rakuoane I, Muhairwe J, Urda L, Amstutz A, Tschumi N, Klimkait T, Labhardt N.D. Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study). HIV Med. 2022;23(3):287-293. DOI: 10.1111/hiv.13189

Brown J.A, Amstutz A, Nsakala B.L, Seeburg U, Vanobberghen F, Muhairwe J, Klimkait T, Daniel Labhardt N. Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial. J Antimicrob Chemother. 2021;76(5):1294-1298. DOI: 10.1093/jac/dkab025

Brown J.A, Mbunkah H.A, Lejone T.I, Ringera I, Cheleboi M, Klimkait T, Metzner K.J, Gunthard H.F, Labhardt N.D, Kouyos R.D, Tschumi N. Emergence of human immunodeficiency virus-1 drug resistance during the 3-month World Health Organization-recommended enhanced adherence counseling period in the CART-1 cohort study. Open Forum Infect Dis. 2021;8(5):ofab046. DOI: 10.1093/ofid/ofab046

Amstutz A, Brown J.A, Ringera I, Muhairwe J, Lejone T.I, Klimkait T, Glass T.R, Labhardt N.D. Engagement in care, viral suppression, drug resistance and reasons for non-engagement after home-based same-day ART initiation in Lesotho: a two-year follow-up of the CASCADE trial. Clin Infect Dis. 2020;71(10):2608-2614. DOI: 10.1093/cid/ciz1126

Brown J.A, Ringera I, Luoga E, Cheleboi M, Kimera N, Muhairwe J, Kayembe B.P, Molapo Hlasoa M, Kabundi L, Yav C.W.D, Mothobi B, Thahane L, Amstutz A, Bachmann N, Mollel G.J, Bresser M, Glass T.R, Paris D.H, Klimkait T, Weisser M, Labhardt N.D. Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania. BMC Infect Dis. 2020;20:773. DOI: 10.1186/s12879-020-05491-9

Lejone T.I, Kopo M, Bachmann N, Brown J.A, Glass T.R, Muhairwe J, Matsela T, Scherrer R, Chere L, Namane T, Labhardt N.D, Amstutz A. PEBRA trial - effect of a peer-educator coordinated preference-based ART service delivery model on viral suppression among adolescents and young adults living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho. BMC Public Health. 2020;20(1):425. DOI: 10.1186/s12889-020-08535-6

Courlet P, Decosterd L.A, Brown J.A, Alves Saldanha S, Marzolini C, Cavassini M, Stoeckle M, Csajka C, Labhardt N.D, Calmy A, Swiss HIV Cohort Study. Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence. J Antimicrob Chemother. 2019;74(8):2468-2470. DOI: 10.1093/jac/dkz181